23,036,271
Vote Records
25,695
Companies
11,771
Funds
3,902
Managers

Home › Companies › REGENXBIO INC. › 2023-2024

REGENXBIO INC. 2023-2024 Proxy Voting Records

Download data (CSV): ballot items · votes by manager · column guide.

Compiled from SEC Form N-PX filings and REGENXBIO INC.’s Form 8-K, filed June 3, 2024 (Item 5.07 on EDGAR). Page generated November 20, 2026.

  • 5Ballot items
  • 212Asset managers, any item
  • 1,346Fund votes
  • May 31, 2024Meeting date

Results at a glance

Meeting of May 31, 2024: 5 items on REGENXBIO INC.’s Form 8-K, filed June 3, 2024: 3 elected · 2 approved.

Dissent

Notable dissent: 1 director (14.4% against).

Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore REGENXBIO INC. in the interactive database Compare manager voting policies

Official 2023-2024 meeting results reported by REGENXBIO INC.

These tallies are REGENXBIO INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 3, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

REGENXBIO INC. — official shareholder meeting results, meeting held May 31, 2024
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: George Migausky 39,124,767---- 1,785,5523,342,209 96%Elected—
Elect Director: Kenneth T. Mills 39,258,562---- 1,651,7573,342,209 96%Elected—
Elect Director: David C. Stump 35,039,630---- 5,870,6893,342,209 86%Elected—
2. The appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ending December 31, 2024 44,152,90058,29341,335 --0 99.9%Approved—
3. The compensation of the Company's named executive officers, as disclosed in the Proxy Statement 40,147,111727,84635,362 --3,342,209 98%Approved—

Source: REGENXBIO INC., Form 8-K, filed with the SEC on June 3, 2024 — read the filing on EDGAR.

How asset managers voted at the REGENXBIO INC. 2023-2024 meeting

212 asset managers disclosed a vote on at least one REGENXBIO INC. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.

Elect Director: David C. Stump

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 3 wordings of this item as funds reported it.

86% Majority: yes · of votes cast

FOR 86%WITHHELD
FOR: 35,039,630WITHHELD: 5,870,689
Details: description as filed, official tally, votes by 68 asset managers

Description as filed by funds: Election of Three Class III Directors: David C. Stump, M.D.

REGENXBIO INC.’s own tally for this item (“Elect Director: David C. Stump”): 35,039,630 for, 5,870,689 withheld, per its Form 8-K filed June 3, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal 1 : By the following vote, the following three persons were elected to serve as Class III directors until the Company's 2027 annual meeting of stockholders:”
Support: 86% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 68 asset managers below reported 15,583,385 for, 2,080,686 withheld, 133,108 abstained, 30,933 not voted.

FOR
FOR: 15,583,385ABSTAIN: 133,108WITHHOLD: 2,080,686NOT VOTED: 30,933
Largest asset managers voting on “Election of Three Class III Directors: David C. Stump, M.D.” at REGENXBIO INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
BlackRock5,145,3060 00For
Vanguard4,787,4210 00For
State Street2,165,7300 030,522For
JPMorgan1,503,6690 00For
Dimensional00 0962,879Withhold
Fidelity912,1520 0100For
Charles Schwab322,6990 00For
Columbia Threadneedle262,0200 00For
AIG/SunAmerica00 0192,183Withhold
Delaware/Macquarie00 0149,000Withhold
Equitable63,1270 052,900Mixed
TIAA00 0104,839Withhold
Direxion Shares ETF Trust00 0104,095Withhold
Jackson National00 102,9230Abstain
Global X91,6200 00For
QUANTITATIVE MASTER SERIES LLC74,4350 00For
American Century00 063,823Withhold
BNY Mellon00 059,339Withhold
Principal1250 046,273Withhold
Prudential/PGIM42,2180 00For
ProShares00 040,884Withhold
Lincoln Financial34,2000 05,071Mixed
Thrivent00 035,111Withhold
Northern Trust00 034,428Withhold
Empower00 00Not Voted

Showing the 25 largest of 68 asset managers. All 68 are in the interactive database (link above).

Elect Director: George Migausky

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 3 wordings of this item as funds reported it.

96% Majority: yes · of votes cast

FOR 96%
FOR: 39,124,767WITHHELD: 1,785,552
Details: description as filed, official tally, votes by 68 asset managers

Description as filed by funds: Election of Three Class III Directors: George Migausky

REGENXBIO INC.’s own tally for this item (“Elect Director: George Migausky”): 39,124,767 for, 1,785,552 withheld, per its Form 8-K filed June 3, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal 1 : By the following vote, the following three persons were elected to serve as Class III directors until the Company's 2027 annual meeting of stockholders:”
Support: 96% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 68 asset managers below reported 16,714,664 for, 1,059,719 withheld, 22,796 abstained, 30,933 not voted.

FOR
FOR: 16,714,664ABSTAIN: 22,796WITHHOLD: 1,059,719NOT VOTED: 30,933
Largest asset managers voting on “Election of Three Class III Directors: George Migausky” at REGENXBIO INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
BlackRock5,145,3060 00For
Vanguard4,787,4210 00For
State Street2,193,3650 02,887For
JPMorgan1,503,6690 00For
Dimensional00 0962,879Withhold
Fidelity912,2520 00For
Charles Schwab322,6990 00For
Columbia Threadneedle262,0200 00For
AIG/SunAmerica192,1830 00For
Delaware/Macquarie149,0000 00For
Equitable63,1270 052,900Mixed
TIAA104,8390 00For
Direxion Shares ETF Trust104,0950 00For
Jackson National89,2510 13,6720Mixed
Global X91,6200 00For
QUANTITATIVE MASTER SERIES LLC74,4350 00For
American Century63,8230 00For
BNY Mellon59,3390 00For
Principal46,3980 00For
Prudential/PGIM42,2180 00For
ProShares40,8840 00For
Lincoln Financial34,2000 05,071Mixed
Thrivent35,1110 00For
Northern Trust34,4280 00For
Empower00 00Not Voted

Showing the 25 largest of 68 asset managers. All 68 are in the interactive database (link above).

Elect Director: Kenneth T. Mills

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 3 wordings of this item as funds reported it.

96% Majority: yes · of votes cast

FOR 96%
FOR: 39,258,562WITHHELD: 1,651,757
Details: description as filed, official tally, votes by 68 asset managers

Description as filed by funds: Election of Three Class III Directors: Kenneth T. Mills

REGENXBIO INC.’s own tally for this item (“Elect Director: Kenneth T. Mills”): 39,258,562 for, 1,651,757 withheld, per its Form 8-K filed June 3, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal 1 : By the following vote, the following three persons were elected to serve as Class III directors until the Company's 2027 annual meeting of stockholders:”
Support: 96% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 68 asset managers below reported 16,767,564 for, 1,006,819 withheld, 22,796 abstained, 30,933 not voted.

FOR
FOR: 16,767,564ABSTAIN: 22,796WITHHOLD: 1,006,819NOT VOTED: 30,933
Largest asset managers voting on “Election of Three Class III Directors: Kenneth T. Mills” at REGENXBIO INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
BlackRock5,145,3060 00For
Vanguard4,787,4210 00For
State Street2,193,3650 02,887For
JPMorgan1,503,6690 00For
Dimensional00 0962,879Withhold
Fidelity912,2520 00For
Charles Schwab322,6990 00For
Columbia Threadneedle262,0200 00For
AIG/SunAmerica192,1830 00For
Delaware/Macquarie149,0000 00For
Equitable116,0270 00For
TIAA104,8390 00For
Direxion Shares ETF Trust104,0950 00For
Jackson National89,2510 13,6720Mixed
Global X91,6200 00For
QUANTITATIVE MASTER SERIES LLC74,4350 00For
American Century63,8230 00For
BNY Mellon59,3390 00For
Principal46,3980 00For
Prudential/PGIM42,2180 00For
ProShares40,8840 00For
Lincoln Financial34,2000 05,071Mixed
Thrivent35,1110 00For
Northern Trust34,4280 00For
Empower00 00Not Voted

Showing the 25 largest of 68 asset managers. All 68 are in the interactive database (link above).

The compensation of the Company's named executive officers, as disclosed in the Proxy Statement

Official resultFund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Approved

Combines 7 wordings of this item as funds reported it.

98% Approved · of votes cast

FOR 98%
FOR: 40,147,111AGAINST: 727,846

Prior year: 97.0% for (June 2, 2023 meeting) ▲ 1.2 pts

Details: description as filed, official tally, votes by 212 asset managers

Description as filed by funds: TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION PAID TO THE COMPANY'S NAMED EXECUTIVE OFFICERS.

REGENXBIO INC.’s own tally for this item (“3. The compensation of the Company's named executive officers, as disclosed in the Proxy Statement”): 40,147,111 for, 727,846 against — passed, per its Form 8-K filed June 3, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 3 : By the following vote, the stockholders approved, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement:”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 69 asset managers voting on “TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION PAID TO THE COMPANY'S NAMED EXECUTIVE OFFICERS.” at REGENXBIO INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
BlackRock5,145,3060 00For
Vanguard4,787,4210 00For
State Street2,196,2520 00For
JPMorgan1,503,6690 00For
Dimensional962,8790 00For
Fidelity912,2520 00For
Charles Schwab322,6990 00For
Columbia Threadneedle262,0200 00For
AIG/SunAmerica192,1830 00For
Delaware/Macquarie149,0000 00For
Equitable116,0270 00For
TIAA104,8390 00For
Direxion Shares ETF Trust104,0950 00For
Jackson National102,9230 00For
Global X91,6200 00For
QUANTITATIVE MASTER SERIES LLC74,4350 00For
American Century63,8230 00For
BNY Mellon59,3390 00For
Principal46,3980 00For
Prudential/PGIM42,2180 00For
ProShares40,8840 00For
Lincoln Financial39,2710 00For
Thrivent35,1110 00For
Northern Trust34,4280 00For
Empower00 00Not Voted

Fund voting reports, all 69 managers: 17,774,439 for, 6,046 against, 18,237 abstained, 30,933 not voted. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 162 asset managers voting on “TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION PAID TO THE COMPANY'S NAMED EXECUTIVE OFFICERS.” at REGENXBIO INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Redmile Group, LLC4,551,5560 00For
JPMorgan3,405,3820 00For
State Street3,002,9840 00For
BlackRock1,812,3421,024 00For
Avidity Partners Management LP1,246,5560 00For
GEODE CAPITAL MANAGEMENT, LLC950,5510 00For
MPM BioImpact LLC549,0780 00For
Northern Trust367,276855 00For
WS MANAGEMENT LLLP351,9180 00For
Charles Schwab343,4470 00For
RTW INVESTMENTS, LP342,4180 00For
Aquilo Capital Management, LLC308,9730 00For
MELLON INVESTMENTS Corp286,1420 00For
ArchPoint Investors221,1970 00For
PRINCIPAL GLOBAL INVESTORS216,2110 00For
Kintegral Advisory, LLC201,9810 00For
JACOBS LEVY EQUITY MANAGEMENT, INC177,5760 00For
Dimensional175,3050 00For
ADAGE CAPITAL PARTNERS GP, L.L.C.165,0730 00For
MACQUARIE INVESTMENT MANAGEMENT BUSINESS TRUST149,0000 00For
PARAMETRIC PORTFOLIO ASSOCIATES LLC138,9050 00For
PANAGORA ASSET MANAGEMENT INC128,6860 00For
BALYASNY ASSET MANAGEMENT L.P.112,4510 00For
STIFEL NICOLAUS & CO INC \MO\106,2390 00For
Nuveen105,7680 00For

Institutional-manager reports, all 162 managers: 21,334,071 for, 371,842 against. Showing the 25 largest; every one is in the interactive database (link above).

The appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the…

Official resultAUDIT-RELATEDReported outcome: Approved

Combines 3 wordings of this item as funds reported it.

99.9% Approved · of votes cast

FOR 99.9%
FOR: 44,152,900AGAINST: 58,293

Prior year: 99.9% for (June 2, 2023 meeting) unchanged

Details: description as filed, official tally, votes by 70 asset managers

Description as filed by funds: To ratify the appointment of PricewaterhouseCoopers LLP by the Audit Committee of the Board of Directors as the Company's independent registered public accounting firm for the year ending December 31, 2024.

REGENXBIO INC.’s own tally for this item (“2. The appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ending December 31, 2024”): 44,152,900 for, 58,293 against — passed, per its Form 8-K filed June 3, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 2 : By the following vote, the stockholders ratified the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ending December 31, 2024:”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 70 asset managers below reported 17,777,404 for, 3,131 against, 18,237 abstained, 30,933 not voted.

FOR
FOR: 17,777,404AGAINST: 3,131ABSTAIN: 18,237NOT VOTED: 30,933
Largest asset managers voting on “To ratify the appointment of PricewaterhouseCoopers LLP by the Audit Committee of the Board of Directors as th” at REGENXBIO INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
BlackRock5,145,3060 00For
Vanguard4,787,4210 00For
State Street2,193,1213,131 00For
JPMorgan1,503,6690 00For
Dimensional962,8790 00For
Fidelity912,2520 00For
Charles Schwab322,6990 00For
Columbia Threadneedle262,0200 00For
AIG/SunAmerica192,1830 00For
Delaware/Macquarie149,0000 00For
Equitable116,0270 00For
TIAA104,8390 00For
Direxion Shares ETF Trust104,0950 00For
Jackson National102,9230 00For
Global X91,6200 00For
QUANTITATIVE MASTER SERIES LLC74,4350 00For
American Century63,8230 00For
BNY Mellon59,3390 00For
Principal46,3980 00For
Prudential/PGIM42,2180 00For
ProShares40,8840 00For
Lincoln Financial39,2710 00For
Thrivent35,1110 00For
Northern Trust34,4280 00For
Empower00 00Not Voted

Showing the 25 largest of 70 asset managers. All 70 are in the interactive database (link above).

Largest REGENXBIO INC. shareholders voting in 2023-2024

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 49,043,000 shares outstanding at the time of that meeting.

Fund voting reports: top REGENXBIO INC. shareholders by shares voted on “TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION PAID TO THE COMPANY'S NAMED EXECUTIVE…”, 2023-2024
#Asset manager % of shares outstanding
1BlackRock 10.49%
2Vanguard 9.76%
3State Street 4.48%
4JPMorgan 3.07%
5Dimensional 1.96%
6Fidelity 1.86%
7Charles Schwab 0.66%
8Columbia Threadneedle 0.53%
9AIG/SunAmerica 0.39%
10Delaware/Macquarie 0.30%
Institutional-manager reports: top REGENXBIO INC. shareholders by shares voted on “TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION PAID TO THE COMPANY'S NAMED EXECUTIVE…”, 2023-2024
#Asset manager % of shares outstanding
1Redmile Group, LLC 9.28%
2JPMorgan 6.94%
3State Street 6.12%
4BlackRock 3.70%
5Avidity Partners Management LP 2.54%
6GEODE CAPITAL MANAGEMENT, LLC 1.94%
7MPM BioImpact LLC 1.12%
8Northern Trust 0.75%
9WS MANAGEMENT LLLP 0.72%
10Charles Schwab 0.70%

Reported REGENXBIO INC. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.

REGENXBIO INC. holdings and ownership disclosed for the 2023-2024 proxy season, with each row’s source and date
HolderShares % outstandingSource, as of
BlackRock6,370,893 12.99%Form 13F, quarter ended March 31, 2024
Redmile Group, LLC4,953,363 10.10%Proxy statement (DEF 14A), proxy filed April 4, 2024
JPMorgan Chase4,037,248 8.23%Form 13F, quarter ended March 31, 2024
Vanguard Group3,338,098 6.81%Form 13F, quarter ended March 31, 2024
State Street3,122,639 6.37%Form 13F, quarter ended March 31, 2024
Entities Affiliated with Allan M. Fox Bryn Mawr Trust Company2,882,466 5.88%Proxy statement (DEF 14A), proxy filed April 4, 2024
Goldman Sachs1,852,214 3.78%Form 13F, quarter ended March 31, 2024
Morgan Stanley1,704,268 3.48%Form 13F, quarter ended March 31, 2024
Dimensional Fund Advisors1,197,073 2.44%Form 13F, quarter ended March 31, 2024
Geode Capital950,551 1.94%Form 13F, quarter ended March 31, 2024

Percentages above are of 49,043,000 shares outstanding, as reported by REGENXBIO INC. on its Form 10-Q dated March 31, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this meeting

At REGENXBIO INC.'s shareholder meeting held May 31, 2024, in the 2023-2024 proxy season, 212 asset managers reported votes on at least one of its 5 ballot items in their SEC Form N-PX filings, covering 1,346 separate fund positions. On the most widely held item on that ballot — TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION PAID TO THE COMPANY'S NAMED EXECUTIVE… — REGENXBIO INC.'s filing reports the proposal as approved, with 98% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: REGENXBIO INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 3, 2024.

Related

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from REGENXBIO INC.’s 10-Q dated March 31, 2024. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.

REGENXBIO INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.

Cite this page

Proxy Votes Now, “REGENXBIO (RGNX) 2024 Annual Meeting: Vote Results & How Funds Voted”, https://proxyvotesnow.com/company/regenxbio-inc/2024 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.